136 related articles for article (PubMed ID: 10958872)
1. Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC).
Eissa S; Ali-Labib R; Khalifa A
Clin Chim Acta; 2000 Oct; 300(1-2):159-69. PubMed ID: 10958872
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the p16 and p15 genes in human bladder tumors.
Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
4. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression.
Swellam M; El-Aal AA; AbuGabel KM
Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816
[TBL] [Abstract][Full Text] [Related]
5. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors.
Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR
Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106
[TBL] [Abstract][Full Text] [Related]
6. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
Southgate J; Proffitt J; Roberts P; Smith B; Selby P
Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
8. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of tumor suppressor genes P16 and P15 in primary maxillofacial squamous cell carcinomas.
Zhao Y; Zhang S; Fu B; Xiao C
Cancer Genet Cytogenet; 1999 Jul; 112(1):26-33. PubMed ID: 10432931
[TBL] [Abstract][Full Text] [Related]
10. p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours.
Le Frère-Belda MA; Cappellen D; Daher A; Gil-Diez-de-Medina S; Besse F; Abbou CC; Thiery JP; Zafrani ES; Chopin DK; Radvanyi F
Br J Cancer; 2001 Nov; 85(10):1515-21. PubMed ID: 11720438
[TBL] [Abstract][Full Text] [Related]
11. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
12. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers.
Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M
Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595
[TBL] [Abstract][Full Text] [Related]
13. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
[TBL] [Abstract][Full Text] [Related]
14. Deletions and point mutations of p16,p15 gene in primary tumors and tumor cell lines.
Yonghao T; Qian H; Chuanyuan L; Yandell DW
Chin Med Sci J; 1999 Dec; 14(4):200-5. PubMed ID: 12894891
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
18. Alteration of p16 and p15 genes in common epithelial ovarian tumors.
Fujita M; Enomoto T; Haba T; Nakashima R; Sasaki M; Yoshino K; Wada H; Buzard GS; Matsuzaki N; Wakasa K; Murata Y
Int J Cancer; 1997 Apr; 74(2):148-55. PubMed ID: 9133447
[TBL] [Abstract][Full Text] [Related]
19. p16 is a major inactivation target in hepatocellular carcinoma.
Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
[TBL] [Abstract][Full Text] [Related]
20. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
Tsutsumi M; Tsai YC; Gonzalgo ML; Nichols PW; Jones PA
Oncogene; 1998 Dec; 17(23):3021-7. PubMed ID: 9881704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]